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Introduction
Selection of appropriate antibacterial agents is the most
important step in causal treatment for infections. Antimi-
crobial agents are clinically used either for cases in which
the pathogen has been identiﬁed or those in which the
pathogen has not been identiﬁed. So far as anaerobic
infections are concerned, treatment is often provided
without exact identiﬁcation of the pathogen. Early stages of
treatment of anaerobic infections are mostly empiric. This
is attributable to the following factors: (1) because non-
spore-forming anaerobes constitute the indigenous ﬂora on
human skin or mucosa, it is difﬁcult to determine whether
or not an isolated strain is the pathogen; (2) identiﬁcation
of anaerobes takes several days; (3) infection with a mix-
ture of anaerobes and aerobes is often seen, and so on.
Therefore, when dealing with infections, it is essential to
select appropriate antibacterial agents, with the possibility
of anaerobic infections taken into account through assess-
ment of the conditions of individual cases.
Features of anaerobic infections
Anaerobic infections can be roughly divided into: (1) non-
spore-forming anaerobic and (2) spore-forming Clostrid-
ium infections. Anaerobic infection is likely to develop in
areas affected by tissue contusion, contamination and
injury, local blood-ﬂow disorders, surgical wounds, aero-
bic infections, etc., because the level of free oxygen is
lower than normal in such areas. Tables 1 and 2 list the
diseases often involving anaerobes as well as the sources
of infection, pathogens and features/signs of anaerobic
infection.
Non-spore-forming anaerobic infection
This is an endogenous infection caused by non-spore-forming
anaerobes found as indigenous bacteria on human mucosa,
etc. This type of infection often causes abscess formation at
poorly ventilated sites (closed cavities). Basic means of
dealing with this type of infection are antibacterial chemo-
therapy and pus elimination (drainage, etc.).
Clostridium infection
This infection is caused by exotoxins produced by bacteria
of Clostridium species. Representative diseases of this type
are tetanus, botulism, gas gangrene and pseudomembra-
nous colitis. All of these conditions are attributable to
toxins. Gas gangrene is caused by the gas and toxins
produced by the bacterium.
Anti-toxin therapy is needed for this type of infection
(excluding pseudomembranous colitis). In cases of
pseudomembranous colitis which develops as a result of
super-infection following antibacterial chemotherapy, the
antibacterial agents used before development of this
disease are discontinued and oral VCM therapy is selected
(Table 3).
Other than these conditions, wound infection and
bacteremia lead to Clostridium species.
Mixed infections with anaerobe and aerobe
A characteristic of anaerobic infections is a high per-
centage of mixed anaerobes and aerobes (60–90%) as
described above (Fig. 1) [1]. Because the areas affected
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by aerobic infection have lower redox potentials than
normal, anaerobic infection is likely to develop, resulting
in a mixed anaerobe and aerobe infection (biphasic
infection).
Therefore, when dealing with infections caused by
anaerobes, possible coexistence of aerobic infection should
also be taken into account and appropriate antibacterial
agents should be selected.
To avoid overlooking anaerobic infections
First consider the possibility of anaerobic infection
Anaerobes serving as pathogens are sometimes overlooked
because they are likely to lose viability, take a long time to
culture and identify, and constitute indigenous ﬂora. When
dealing with cases showing signs of infections often
Table 1 Anaerobic infections and their major pathogens
Type Disease Pathogen
Trauma Tetanus, gas gangrene Clostridium tetani
C. perfringens, C. novyi
C. septicum, etc.
Superinfection, food poisoning Pseudomembranous colitis, botulism C. difﬁcile
C. botulinum
Oral infection with indigenous
anaerobes
Brain abscess, subdural/epidural abscess, sinusitis,
otitis media, ocular infection, aspiration
pneumonia, lung abscess, empyema, dental
infection
Prevotella species
Porphyromonas species
Fusobacterium species
Peptostreptococcus species
Parvimonas species
Gastrointestinal infection
with indigenous anaerobes
Infection after gastrointestinal surgery, peritonitis,
intraperitoneal abscess, intraperitoneal infection
(hepatic/subdiaphragmatic abscess, etc.), perianal
abscess, biliary tract infection, bedsore, skin
abscess, diabetic ulcer
Bacteroides fragilis group
Bilophila wadsworthia
Peptostreptococcus species
Clostridium species
Finegoldia species
Parvimonas species
Peptoniphilus species
Female genital tract infection
(mostly due to gastrointestinal
indigenous anaerobes)
Endometritis, ovarian abscess, puerperal fever B. fragilis group
Peptostreptococcus species
Prevotella species
Clostridium species
Finegoldia species
Parvimonas species
Peptoniphilus species
Systemic infection Bacteremia, infectious endocarditis B. fragilis group
Peptostreptococcus species
Parvimonas species
Table 2 Features/signs suggesting anaerobic infection
Puriform secretion, malodorous
Infection with closed cavities (empyema, etc.)
Gram-positive pus, negative on aerobic culture
Infection during the use of antibacterial agents
ineffective against anaerobes
Sign of gas pooling within foci of infection
Infection associated with malignant tumors
Trauma, contusion, necrosis (gas gangrene, tetanus)
Diarrhea during the use of antibacterial agents (pseudomembranous
colitis)
Table 3 Clostridium infections
Disease Pathogen Antibacterial agents
Tetanus C. tetani Benzylpenicillin
(penicillin G), etc.
Gas gangrene C. perfringens Benzylpenicillin
(penicillin G), etc.C. septicum
C. novyi, etc.
Botulism C. botulinum Benzylpenicillin
(penicillin G), etc.
Pseudomembranous
colitis
C. difﬁcile Vancomycin
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involving anaerobes (Table 1) or features of anaerobic
infection (Table 2), empiric therapy based on recognition
of possible involvement of anaerobes needs to be
administered.
Maintain close cooperation with the microbiology
laboratory
In cases in which anaerobic infection is suspected, reporting
of this suspicion by the clinical department to the microbi-
ology laboratory is very important in achieving smooth and
precise testing. Responses to gram staining provide useful
information since anaerobes can differ slightly from aer-
obes in terms of chromatic responses and morphological
features.
Selection of antibacterial agents
Table 4 lists representative antibacterial agents used for
anaerobic infections. Anaerobes are resistant to only a
limited number of antibacterial agents. However, since the
susceptibility of anaerobes to antibacterial agents can vary,
it is essential to have updated information on the suscep-
tibility trends of anaerobes on a nation-wide level, in each
district and at each facility. The mechanism for resistance
of anaerobes to drugs resembles that known for bacteria in
general. Among others, b-lactamase production is an
important mechanism (Table 5) [2]. Care is needed
regarding the recent ﬁnding that metallo-b-lactamase-pro-
ducing strains were found among Bacteroides fragilis [3]
and that some strains of this bacterium showed resistance
to drugs of the ﬂuoroquinolones [4].
Other therapies
1. Abscesses cannot be treated adequately with antibac-
terial agents alone. Surgical manipulations (incision,
drain insertion, drainage, etc.) are also needed.
Lower respiratory infection
᧤30 cases)
Intraperitoneal infection
(246 cases᧥
Urogenital infection
(226 cases᧥
90.7% 74.8%80%
Skin and soft tissue infection
(171 cases)
Bacteremia
(42 cases᧥
Anaerobe alone19%
Anaerobe+Aerobe
59 1%.
Fig. 1 Simultaneous isolation
of anaerobes and aerobes from
clinical samples (source: Ref.
[1])
Table 4 Major antibacterial agents used for anaerobic infections
Effective agents Carbapenems
Penicillins with b-lactamase inhibitors
Third and fourth generation cephems
Cephamycins
Lincomycins
Ineffective agents Aminoglycosides
Monobactams
Polypeptides
Old quinolones
Table 5 b-Lactamase-producing anaerobes (source: Ref. [2])
Bacteroides fragilis group
B. splanchnicus
Pigmented Prevotella species
Porphyromonas species
Prevotella oralis group
P. oris, P. disiens
Bilophila wadsworthia
Fusobacterium nucleatum
F. mortiferum, F. varium
Clostridium ramosum
C. clostridioforme
C. butyricum
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2. Areas affected by contusion or contamination follow-
ing trauma require wound disinfection by hydrogen
peroxide and debridement (for the prevention of
tetanus and gas gangrene).
3. Anti-toxin therapy: When dealing with tetanus,
penicillins are combined with anti-tetanus human
immunoglobulin and tetanus toxoid. When dealing
with gas gangrene and botulism, penicillins are
combined with anti-toxin therapy. Other than these
therapies, respiratory management is used for tetanus
and oxygen under high pressure (OHP) therapy for
gas gangrene.
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